Gilead Increases Investment In Arcus; Firms Abandon Chemo-Free Combo Study

 
• By Joseph Haas
Gilead HQ
Gilead increases its investment in Arcus and the anti-TIGIT mechanism • Source: Shutterstock

More from Strategy

More from Business